What is SimulStat?
SimulStat is a specialized provider of staffing solutions tailored for the biostatistics and epidemiology sectors, primarily catering to the pharmaceutical and biotechnology industries. Since its establishment in 2001, the company has built a robust reputation for supplying highly skilled biometric and real-world data professionals. SimulStat offers a comprehensive suite of services, including staff augmentation, outsourcing solutions, contract staffing, functional service provision, and end-to-end project outsourcing, addressing critical talent needs within these highly regulated fields.
How much funding has SimulStat raised?
SimulStat has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for SimulStat?
The recent major strategic investment signals a pivotal growth phase for SimulStat. This capital infusion is expected to fuel further expansion of its service offerings and market reach within the biopharmaceutical ecosystem. The company is strategically positioned to capitalize on the increasing demand for specialized data and statistical expertise, likely focusing on enhancing its talent acquisition capabilities and broadening its client base to support complex research and development initiatives.
See full SimulStat company page
